Bo Yang
15Patents
2h-index
60Co-inventors
53Inventor score
Filing activity: Jul 27, 2007 → Nov 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7910702B2 | Recombinant antibodies to sclerotinia antigens | Chemistry; Metallurgy | 13 | Active |
| US8293972B2 | Recombinant antibodies to Sclerotinia antigens | Chemistry; Metallurgy | 3 | Active |
| US10233180B2 | Substituted nitrogen-containing heterocyclic derivatives, pharmaceutical compositions comprising the same and applications of antitumor thereof | Chemistry; Metallurgy | 1 | Active |
| US10723869B2 | Polypropylene composition and preparation method thereof, and film or sheet prepared from the polypropylene composition and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11534448B2 | Use of canagliflozin in preparation of antitumor drug | Human Necessities | 0 | Active |
| US12350301B2 | Composition comprising three Lactobacillus sp. strains, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US9856288B2 | Tripeptide epoxyketone compound constructed by heterocycle and preparation method and use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12409203B2 | Polypeptide dimer with high sialic acid content, comprising extracellular domain of alpha subunit of IGE FC receptor, and pharmaceutical composition comprising same | Chemistry; Metallurgy | 0 | Active |
| US11248032B2 | Method for producing soluble recombinant human-basic fibroblast growth factor (rh-bFGF) | Human Necessities | 0 | Active |
| US11254723B2 | Recombinant human-basic fibroblast growth factor (rh-bFGF) and pharmaceutical composition comprising rh-bFGF | Human Necessities | 0 | Active |
| US11319300B2 | Polyfluoro-substituted aromatic heterocyclic derivative, pharmaceutical composition containing same, and applications thereof | Chemistry; Metallurgy | 0 | Active |
| US11834648B2 | Human induced pluripotent stem cell lines for modeling Alzheimer's disease and usage thereof | Physics | 0 | Active |
| US11278542B2 | Use of nicotinamide composition in preparation of drug for treating hand-foot skin reaction induced by sorafenib | Human Necessities | 0 | Active |
| US11987797B2 | Attenuated strain of African swine fever virus (ASFV) with IPTG-induced deletion of D1133L gene and use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11883411B2 | Use of compound aprepitant in preparation of drug for preventing or treating African swine fever (ASF) | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.